Personal history of autoimmune diseases and risk of MM with more than 5 years' latency
| Category or condition . | MM patients (n = 19 112) . | MM controls (n = 75 408) . | OR* (95% CI) [P] . |
|---|---|---|---|
| Autoantibodies detectable | 171 | 788 | 0.8 (0.72-1.00) |
| Systemic involvement | 96 | 467 | 0.8 (0.6-1.00) |
| Rheumatoid arthritis | 72 | 388 | 0.7 (0.6-0.9) |
| Autoimmune hemolytic anemia | 0 | 0 | |
| Autoantibodies not detectable | 111 | 366 | 1.2 (0.96-1.5) |
| Polymyalgia rheumatica | 29 | 44 | 2.6 (1.6-4.1) |
| Giant cell arteritis | 6 | 3 | 7.7 (1.9-31.0) |
| Category or condition . | MM patients (n = 19 112) . | MM controls (n = 75 408) . | OR* (95% CI) [P] . |
|---|---|---|---|
| Autoantibodies detectable | 171 | 788 | 0.8 (0.72-1.00) |
| Systemic involvement | 96 | 467 | 0.8 (0.6-1.00) |
| Rheumatoid arthritis | 72 | 388 | 0.7 (0.6-0.9) |
| Autoimmune hemolytic anemia | 0 | 0 | |
| Autoantibodies not detectable | 111 | 366 | 1.2 (0.96-1.5) |
| Polymyalgia rheumatica | 29 | 44 | 2.6 (1.6-4.1) |
| Giant cell arteritis | 6 | 3 | 7.7 (1.9-31.0) |
When no case patient or control subject has the specific condition, P values (2-sided) based on Fisher exact test are given.